HomeTHYROCARE • NSE
add
Thyrocare Technologies Ltd
Previous close
₹389.95
Day range
₹376.50 - ₹394.90
Year range
₹219.33 - ₹536.67
Market cap
62.82B INR
Avg Volume
375.99K
P/E ratio
45.37
Dividend yield
1.48%
Primary exchange
NSE
Market news
Financials
Income Statement
Revenue
Net income
| (INR) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 1.96B | 17.85% |
Operating expense | 763.70M | 25.20% |
Net income | 290.10M | 51.81% |
Net profit margin | 14.84 | 28.82% |
Earnings per share | 2.11 | 78.20% |
EBITDA | 477.75M | 39.42% |
Effective tax rate | 20.74% | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.92B | 39.87% |
Total assets | — | — |
Total liabilities | — | — |
Total equity | 5.34B | — |
Shares outstanding | 159.16M | — |
Price to book | 11.61 | — |
Return on assets | — | — |
Return on capital | 16.20% | — |
Cash Flow
Net change in cash
| (INR) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | 290.10M | 51.81% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Thyrocare Technologies Limited is an Indian multinational chain of diagnostic and preventive care laboratories, headquartered in Navi Mumbai. As of 2021, the company has a total of 1,122 outlets and collection centers across India and parts of Nepal, Bangladesh and the Middle East.
On 26 June 2021, Indian e-pharmacy and online healthcare aggregator PharmEasy's parent API Holdings acquired a 66.1% controlling stake in Thyrocare, making Thyrocare the first Indian listed company to be acquired by a startup. Wikipedia
Founded
1996
Headquarters
Website
Employees
1,822
